We have also identified CORT-regulated targets and associated GR binding sites which may have key roles in the development of metabolic syndrome phenotypes in gluconeogenesis, de novo lipogenesis, substrate production for triglyceride synthesis as well as lipoprotein function. This evidence concerns the gene NR3C1 and metabolic syndrome.